Logo

Amersham Pharmacia Gets NHGRI Grant for Genomic Technology Development

Jan 28, 2000
Premium

S

UNNYVALE, Calif.--Amersham Pharmacia Biotech has been awarded a grant by the US National Human Genome Research Institute under a new program called Advanced Development of Genomic Technologies that is emphasizing DNA sequencing technologies. Amersham will work with researchers from Northeastern University in Boston and Washington University School of Medicine in St. Louis to develop a new generation of DNA sequencers.

Filed under

Informatics
Breaking News
The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.